Company Shanrong Biotechnology Corp. Other OTC

SRBT

US81946R1077

Managers

Members of the board

Share class

Company contact information

Sector

Sector Shell Companies

Inactive Instrument

Shanrong Biotechnology Corp. is a holding company for select biotechnology, health, and wellness operations. The Company owns and operates three patents: Long-lasting preparation of long-term stable intravenous melatonin injectable addressing sepsis, bacterial pathologies, and other inflammatory pathology; new melatonin formulations for the treatment of chemotherapy-resistant tumors addressing cancer (head and neck, prostate, breast, ovarian, melanoma) and injectable melatonin composition for the treatment of viral diseases addressing COVID-19 and other viral diseases.

Managers	Title	Age	Since
Frank Igwealor CEO	Chief Executive Officer	53	21-08-30
Qingping Zheng BRD	Director/Board Member	-	-
Guenter Volgger PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
Frank Igwealor CEO	Chief Executive Officer	53	21-08-30
Qingping Zheng BRD	Director/Board Member	-	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	484,853	188,840 ( 38.95 %)	0	38.95 %

Shanrong Biotechnology Corp.

Building 10, Hetai Garden 555 Hutai Road

2000070, Shanghai

address Shanrong Biotechnology Corp.(SRBT)

Financials

Holding Companies

Holding Companies

Investment Holding Companies

Shell Companies

	1st Jan change	Capi.
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+166.80%	6.38B
SCREAMING EAGLE ACQUISITION CORP.	+1.65%	1.01B
CHURCHILL CAPITAL CORP VII	+2.05%	981M
APPLE ISPORTS GROUP, INC.	+41.91%	872M
PERELLA WEINBERG PARTNERS	+24.28%	812M
ARES ACQUISITION CORPORATION II	+1.72%	664M
E7 GROUP	+1.80%	617M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ALTC ACQUISITION CORP.	+36.55%	622M

Shell Companies